Mundipharma International and the Mundipharma independent associated companies are committed to improving the health and quality of life of people everywhere. Over the past 50 years the network of independent associated companies has become a leader in pain management, and through a shared spirit of innovation is building a growing presence in the oncology, rheumatoid arthritis and respiratory markets. The Mundipharma network of independent associated companies has a presence in 48 countries worldwide and joint ventures in: Cyprus, India and Israel. In 2013 Mundipharma announced the opening of offices in Mexico, Brazil and Colombia to consolidate its presence in Latin America.
Contact details
Mundipharma de México S de RL de CV
Javier Barros Sierra 540
Torre 1 Piso 7
Col. Lomas de Santa Fe
CP 01210 México DF
MEXICO
Tel: +52 (55) 6585 0610
Website: www.mundipharma.com
During 2013 Mundipharma entered Brazil, Mexico and Colombia to consolidate its presence in the Latin American region. The general director for Mexico discusses the company’s plans to become leader in…
Novartis Mexico Country President Fernando Cruz outlines the new normal for Mexican healthcare post-regulatory reform, how the company’s global reshuffle has impacted Mexican operations, and the challenges inherent in bringing…
David López García, Mexico country manager of global rare genetic therapy player Biomarin, outlines the challenging situation around patient access to orphan drugs in Mexico and the importance of building…
Dr David Kershenobich Stalnikowitz, director-general of the Salvador Zubirán National Institute of Medical Sciences and Nutrition (INCMNSZ) shares the many new initiatives the Institute has introduced in the past couple…
In the historic year of their 70th anniversary, Cristóbal Thompson, executive director of the Asociación Mexicana de Industrias de Investigación Farmacéutica (AMIIF), the association for research-based pharmaceutical companies in Mexico,…
Rafael Gual Cosío, director general of the Cámara Nacional de la Industria Farmacéutica (CANIFARMA), the umbrella industry association for the healthcare sector in Mexico, shares his perspectives on the complex…
The election of populist President Andres Manuel Lopez Obrador (AMLO) on 1 July 2018 heralded a new era of hope and optimism for Mexicans. In the first 13 months of…
Juan de Villafranca, executive director of the Asociacion Mexicana de Laboratorios Farmaceuticos (AMELAF), shares the exciting new initiatives he has launched in the past two years of his term; the…
Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms president Andres Manuel Lopez Obrador is prioritising, latest news on the INSABI program,…
Between 2015 and 2017 PharmaBoardroom met with pharma country managers in Mexico who spoke about the challenges and opportunities present in the Mexican market. Since then, these five stakeholders have…
The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP protection and enforcement and market access barriers for…
What traits, competencies and drivers do you need to be a successful pharma country manager in today’s dynamic Mexican pharma market? Jose Guerrero and Male Mejido from the Mexico office…
Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma has made in countering corruption, the areas in which urgent improvement is still needed, and outlines the three…
See our Cookie Privacy Policy Here
